Foamix Pharmaceuticals Ltd (FOMX) Return on Assets ROA from the fourth quarter of 2019 to fourth quarter of 2018 and for the year 2019, Average High and Low, Fundamental Ratios from Dec 31 2019 to Dec 31 2018 - CSIMarket
CSIMarket
 


Foamix Pharmaceuticals Ltd   (FOMX)


Foamix Pharmaceuticals Ltd 's ROA from the fourth quarter of 2019 to the fourth quarter of 2018 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Foamix Pharmaceuticals Ltd 's ROA in the fourth quarter of 2019?
Foamix Pharmaceuticals Ltd achieved a return on average assets (ROA) of 98.28 % in its fourth quarter of 2019, this is above FOMX's average return on assets of 51.61%.
Foamix Pharmaceuticals Ltd assets over the 12 months ending in its fourth quarter of 2019 are valued at $97 million

ROA has improved compared to 74.47% in the third quarter of 2019, due to net income growth.

However, within the Consumer Non Cyclical sector only one company had a higher return on assets. While Return on assets, overall ranking has advanced in the Dec 31 2019 quarter, so far to 43, from total ROA ranking in the third quarter of 2019 at 61.

What is ROA?



Return On Assets (Dec 31 2019)
IV. Quarter
(Sep 30 2019)
III. Quarter
(Jun 30 2019)
II. Quarter
(Mar 31 2019)
I. Quarter
(Dec 31 2018)
IV. Quarter
Y / Y Total Assets Change 2.69 % -23.57 % 87.31 % 74.81 % 14.69 %
Y / Y Net Income Change 168.65 % 49.62 % 1.96 % -41.47 % -
Net Income (TTM) in million 95 71 64 63 74
Return On Assets (TTM) 98.28 % 74.47 % 62.31 % 67.86 % 88.39 %
FOMX's Total Ranking # 43 # 61 # 81 # 91 # 76
Total Assets (TTM) in million 139 83 76 89 135
Seq. Total Assets Change 67.8 % 8.43 % -13.9 % -34.45 % 24.89 %
Seq. Net Income Change 63.29 % 21.94 % 24.92 % 8 % -9.06 %



Return On Assets Company Ranking
Within: No.
Industry # 1
Sector # 2
Overall # 38

Return On Assets Statistics
High Average Low
115.88 %
51.61 %
-31.29 %
(Dec 31 2019)   (Dec 31 2017)





Financial Statements
Foamix Pharmaceuticals Ltd 's Assets $ 139 million FOMX's Balance sheet
Foamix Pharmaceuticals Ltd 's Income $ 38 million Quarterly FOMX's Income Statement
FOMX's Income by Division See FOMX's Income by Division



Annual Return On Assets (Dec 31 2019)
FY 2019
(Dec 31 2018)
FY 2018
(Dec 31 2017)
FY 2017
(Dec 31 2016)
FY 2016
(Dec 31 2015)
FY 2015
Y / Y Total Assets Change 2.69 % 14.69 % -30.08 % 27.1 % 128.25 %
Total Assets in million 139 135 118 169 133
Y / Y Net Income Change 28.34 % 12.86 % 124.01 % 77.61 % 43.83 %
Net Income in million 95 74 66 29 17
Annual Return On Assets 68.4 % 54.73 % 55.62 % 17.36 % 12.42 %




Comment on FOMX's ROA in the fiscal year ending 2019
In the fiscal year 2019 ROA improved to 68.4 % compared to prior year, due to annual net income growth of 28.34 % to $95.18 million, while value of Foamix Pharmaceuticals Ltd 's overall assets grew just by 2.69 % to $139.14 million, compared to $139.14 a year before.


More Return On Assets Ratios
FOMX's' Return on Assets at Yahoo Finance
Legal Cannabis Industry Return On Assets Trends and Statistics
Consumer Non Cyclical Sector Roa Statistics
Roa Trends for overall market
FOMX's Roa Ratio versus Legal Cannabis Industry, Consumer Non Cyclical Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for FOMX's Competitors
Subscribers only: Roa for Foamix Pharmaceuticals Ltd 's Suppliers
Subscribers only: Return On Assets for FOMX's Customers

You may also want to know
FOMX's Roi FOMX's Inventory Turnover Ratio FOMX's Growth Rates FOMX's Dividend Comparisons
FOMX's Profitability Ratios FOMX's Asset Turnover Ratio FOMX's Dividend Growth
FOMX's Roe FOMX's Valuation Ratios FOMX's Financial Strength Ratios FOMX's Dividend Payout Ratio



Companies with similar Return On Assets at Dec 31 2019, within Consumer Non Cyclical Sector ROA
Stryve Foods Inc   192.56 %
Cronos Group Inc   174.36 %
Foamix Pharmaceuticals Ltd   115.88 %
U S Premium Beef Llc  53.50 %
Eos Inc   51.57 %
Ambev S a   48.15 %
Fitlife Brands Inc   42.48 %
Medifast Inc   38.20 %
United guardian Inc   36.37 %
Cvr Partners Lp  32.35 %
Cat9 Group Inc   30.11 %
Golden Growers Cooperative  27.78 %
National Beverage Corp   23.72 %
The Davey Tree Expert Company  23.33 %
Monster Beverage Corp  22.13 %
Healthy Extracts Inc   19.79 %


Date modified: 2026-09-18T13:11:04+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.